Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

Factsheet describing the efficacy and safety of a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

Factsheet describing the treatment of Waldenström's macroglobulinemia (WM) by inhibiting BTK.

Overview of current approaches for the management of patients with chronic lymphocytic leukemia (CLL) presented at the 7^th ESH Translational Research Conference on Lymphoid Malignancies.